AB0564 Continuation and remission rates of tocilizumab...

AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry

Asai, N., Kobayakawa, T., Saito, K., Shioura, T., Yabe, Y., Kojima, T., Kaneko, A., Ishiguro, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.564
Date:
June, 2013
File:
PDF, 50 KB
english, 2013
Conversion to is in progress
Conversion to is failed